| 1 |
35256943 | The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration. | 2022 Feb |
1 |
| 2 |
31646730 | COX-2/sEH dual inhibitor PTUPB alleviates bleomycin-induced pulmonary fibrosis in mice via inhibiting senescence. | 2020 Apr |
1 |
| 3 |
29386571 | Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation. | 2018 Jan 31 |
2 |
| 4 |
21185940 | The RhoGAP domain-containing protein, Porf-2, inhibits proliferation and enhances apoptosis in neural stem cells. | 2011 Mar |
2 |
| 5 |
15803328 | Increased expression of p53 and p21 (Waf1/Cip1) in the lesional skin of bleomycin-induced scleroderma. | 2005 May |
9 |
| 6 |
15003936 | Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis. | 2004 Apr |
1 |
| 7 |
15507241 | Increase in p21 expression independent of the p53 pathway in bleomycin-induced lung fibrosis. | 2004 Dec |
4 |
| 8 |
10657022 | Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. | 2000 Feb |
1 |
| 9 |
10783125 | Bleomycin-mediated pulmonary toxicity: evidence for a p53-mediated response. | 2000 May |
1 |
| 10 |
10514416 | The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine. | 1999 Oct |
1 |